Cure8 research brief
This project tests whether common nanoplastics that people ingest could damage the gut barrier, alter gut microbes’ estrogen metabolism, and injure enteric nerves — processes that might increase risk or severity of IBD.
If confirmed, nanoplastics would be a potentially modifiable environmental contributor to intestinal inflammation. The work links environmental exposure research to IBD mechanisms and patient samples, which could point to new prevention or therapy targets beyond current immune-focused treatments.
Researchers studying environmental drivers of IBD, gastroenterologists and clinicians focused on gut barrier and neuroimmune mechanisms, and patients and advocates interested in environmental risk factors for IBD.
This is a funded NIH project record (R00 phase) from Emory University proposing to study how bisphenol A–containing nanoplastics (BPA-NPs) affect intestinal barrier integrity, the estrobolome (microbial estrogen metabolism), and enteric nervous system (ENS) mitochondrial function to drive neurogenic inflammation and worsen colonic injury.
Planned work includes cell co-cultures, murine exposure models, human organoids and ex vivo tissues, spatial transcriptomics, Seahorse bioenergetics, exposomics of patient biopsies/serum/stool, and correlation of nanoplastics burden with mechanistic markers. The entry describes aims, methods, and training goals but does not report completed clinical results.
This is a funded research project record (project summary) describing planned and ongoing studies; it does not present peer-reviewed results. Findings will depend on future experimental and exposomics data. Interpret outcomes cautiously until peer-reviewed publications are available.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Institute of Diabetes and Digestive and Kidney Diseases - K99DK149050 - $90,000
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Understanding gene–microbe interactions that drive site-specific disease in very early-onset Crohn’s could reveal why some children develop ileal versus colonic disease and suggest new approaches to prevention or...
FUT2-mediated fucosylation shapes gut glycans and the microbiome, mechanisms relevant to inflammation and mucosal barrier function in IBD. Understanding these pathways could point to future biomarkers or therapeutic...
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
